Trichophyton indotineae: A newly identified dermatophyte species first reported in India, causing widespread dermatophytosis.
Drug Resistance: Resistance to standard antifungal medications like terbinafine and itraconazole has been observed due to genetic mutations.
Misuse of Steroids: The inappropriate use of steroid creams has contributed significantly to the rise of drug-resistant strains.
Symptoms: Common symptoms include persistent, treatment-resistant rashes that are often red, scaly, and itchy.
Diagnosis: Requires clinical examination and laboratory tests, such as fungal cultures and molecular diagnostics.
Geographical Spread: Initially identified in India, this fungus has now spread to several countries.
Public Health Concern: The rise of drug-resistant fungal infections poses a significant challenge to healthcare providers and patients.
Impact of Misdiagnosis: Misdiagnosis can lead to ineffective treatments and worsening of the infection.
Prevention: Emphasizes good hygiene practices, including keeping the skin dry and clean, and avoiding the sharing of personal items.
Treatment Challenges: Resistance to antifungals and the side effects of alternative treatments make managing these infections difficult.
